SOPHiA GENETICS SA (SOPH)
NASDAQ: SOPH · Real-Time Price · USD
8.43
+0.03 (0.30%)
At close: Sep 1, 2026, 4:00 PM EDT
8.43
0.00 (0.00%)
After-hours: Sep 1, 2026, 4:10 PM EDT
SOPHiA GENETICS Market Cap
SOPHiA GENETICS has a market cap or net worth of $717.2 million as of September 1, 2026. Its market cap has increased by 206.73% in one year.
Market Cap
717.20M
Enterprise Value
671.36M
1-Year Change
206.73%
Ranking
Category
Stock Price
$8.43
ChartMarket Cap Chart
Since the IPO on July 23, 2021, SOPHiA GENETICS's market cap has decreased from $1.12B to $717.20M, a decrease of -35.98%. That is a compound annual growth rate of -8.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 717.20M | 126.36% |
| Dec 31, 2025 | 316.85M | 55.34% |
| Dec 31, 2024 | 203.97M | -33.51% |
| Dec 29, 2023 | 306.77M | 131.92% |
| Dec 30, 2022 | 132.27M | -85.31% |
| Dec 31, 2021 | 900.39M | -19.63% |
| Jul 23, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Certara | 1.24B |
| GoodRx Holdings | 1.18B |
| Teladoc Health | 1.14B |
| HealthStream | 867.55M |
| Phreesia | 731.85M |
| Claritev | 666.88M |
| Weave Communications | 583.99M |
| Evolent Health | 483.89M |